Navigation Links
Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research
Date:10/14/2010

ANN ARBOR, Mich., Oct. 14 /PRNewswire/ -- The U.S. Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE) has selected Thomson Reuters to develop a secure, interactive tool that will enable researchers to perform comparative effectiveness studies without the need for professional computer programming.

(Logo: http://photos.prnewswire.com/prnh/20090507/NY12658LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090507/NY12658LOGO)

Comparative effectiveness research (CER) evaluates medical treatments to determine which work best in real-world settings. The American Recovery and Reinvestment Act allocated $1.1 billion to support CER. ASPE administrators believe that a tool that summarizes data files without the need for complicated programming will facilitate CER.

CER studies often depend on aggregating data housed in disparate databases — which requires researchers to start each study from scratch and to process, clean, and format administrative data. This project is designed to build a tool that will simplify that process by making the clinical and administrative health information housed in federal and state databases and the Thomson Reuters MarketScan® databases accessible to researchers using next-generation analytical applications.

The Thomson Reuters MarketScan databases house integrated patient-level data for populations covered by commercial insurance, Medicaid, and Medicare supplemental plans. This information includes inpatient, outpatient, drug, laboratory, and other data reflecting real-world treatment patterns and costs.

As part of the project, Thomson Reuters will develop a pilot system linking multiple healthcare data sources and test it by conducting two high-priority analyses on care delivery options for selected medical conditions.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries.  For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ziehm Imaging Provides Germanys Federal Armed Forces (Bundeswehr) With Mobile X-Ray Systems
2. NeoStem Comments on Recent Court Ruling Blocking the Federal Governments Funding of Embryonic Stem Cell Research
3. Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen (rPA) From Anthr
4. New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals, Biologics to Federal Government
5. Federal Agents Seize FastSize Extenders and FastSize EQM™ Erectile Quality Monitors
6. Federal Appeals Court Rules Pharmaceutical Sales Reps Entitled to Overtime Pay
7. St. Jude Medical and Hospitals in Ohio and Kentucky to Pay Almost $4 Million to Federal Government to Resolve Fraud Allegations
8. Total Federal Grant Funds for Indiana Health Information Technology Efforts Climb to Nearly $50 Million; Latest $16 Million Installment Spotlights Indiana Health Information Exchange in Delivering Higher Quality and Higher Value Healthcare Through M
9. Federal Aviation Administration Selects Partners For Nationwide AED Program
10. Chesley Files Federal Zicam Lawsuits
11. Federal Judge Rejects GlaxoSmithKlines Claims of Privilege
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Hungary , Feb. 11, 2016 ... the unmet medical need of pulmonary and respiratory diseases ... The program focusing on COPD and asthma patients show ... --> --> Upper ... healthcare problems in the developed world and reached epidemic ...
(Date:2/11/2016)... February 11, 2016 ,   ... EUR 1,377.2m  Adjusted EBITDA climbs to EUR 277.9m   ... 3.41  Proposed dividend of EUR 0.85 per share (2014: ... tubing business and refinancing successfully completed  Approximately 9% ... organic basis  Adjusted EBITDA expected for 2016 at ...
(Date:2/10/2016)... 11, 2016 http://www.researchandmarkets.com/research/rp4pg8/molecular ... "Molecular Diagnostics Reports Bundle" report ... ) has announced the addition of the ... to their offering. --> Research ... the addition of the "Molecular Diagnostics ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... ... diabetes has been gearing up for their simultaneous grand openings in March. All ... right now that you’re probably wondering, is reversing diabetes possible? According to this ...
(Date:2/11/2016)... Plantation, Fla. (PRWEB) , ... February 11, 2016 ... ... CareTRAK™, an unparalleled clinical decision support technology, with highly adaptable algorithms, has ... cases. When a patient has signs and symptoms consistent with Zikas and a ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... of a master charity program created to assist the people of their local ... closely with nonprofit organizations and community leaders. Their hope is to bring awareness ...
(Date:2/11/2016)... ... ... Dickinson Insurance & Financial Services continues their commitment to act as Agents ... local boy named Barrett, who has been fighting ALL leukemia for almost two years. ... all local families dealing with childhood cancer. Information on how to help is now ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hoggan Scientific, ... gauges used in physical therapy, occupational therapy and sports medicine clinics, hospitals, universities ... exercise and therapy, introduces its new microFET Digital Pinch Gauge. , Hoggan ...
Breaking Medicine News(10 mins):